
Sign up to save your podcasts
Or


Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis.
Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00097-7/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
 By The Lancet Group
By The Lancet Group5
11 ratings
Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis.
Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00097-7/fulltext
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

320 Listeners

497 Listeners

2 Listeners

37 Listeners

366 Listeners

22 Listeners

0 Listeners

0 Listeners

2 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

16,083 Listeners

1 Listeners

1 Listeners

0 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

909 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners